pyrrolidonecarboxylic acid has been researched along with Blood Clot in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bakulin, DA; Charushin, VN; Ezhikova, MA; Kodess, MI; Krasnov, VP; Levit, GL; Matveeva, TV; Nizova, IA; Slepukhin, PA; Tyurenkov, IN; Vigorov, AY | 1 |
Fang, W; Li, Y; Liu, Y; Luo, W; Xi, T; Xiong, J; Yang, H | 1 |
Anil Kumar, KS; Bajaj, K; Barthwal, MK; Dikshit, DK; Dikshit, M; Jain, M; Misra, A; Shandilya, S; Shukla, P; Srivastava, S | 1 |
Bai, L; Fang, W; Huo, J; Kong, Y; Xiong, J; Yunman, L | 1 |
Bai, L; Cen, J; Fang, W; Fu, J; Kong, Y; Li, Y; Xiong, J | 1 |
Conkie, JA; Davidson, JF; McCall, F; Walker, ID | 1 |
6 other study(ies) available for pyrrolidonecarboxylic acid and Blood Clot
Article | Year |
---|---|
Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides.
Topics: Aged; Amides; Fibrinolytic Agents; Humans; Peptides; Platelet Aggregation Inhibitors; Pyrrolidonecarboxylic Acid; Thrombosis | 2023 |
Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).
Topics: Animals; Crotalid Venoms; Dose-Response Relationship, Drug; Drug Synergism; Fibrinolytic Agents; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis; Treatment Outcome | 2015 |
Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids.
Topics: Animals; Blood Coagulation; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Hemorrhage; Humans; Mice; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrrolidonecarboxylic Acid; Thrombosis | 2016 |
Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Topics: Adenosine Diphosphate; Animals; Anticoagulants; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Molecular Structure; Molecular Weight; Oligopeptides; Platelet Aggregation; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis; Whole Blood Coagulation Time | 2009 |
New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Fibrinolytic Agents; Male; Oligopeptides; P-Selectin; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis | 2012 |
Measurement of protein C in plasma--a fully automated assay.
Topics: Anticoagulants; Autoanalysis; Clinical Enzyme Tests; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Protein C; Pyrrolidonecarboxylic Acid; Thrombosis | 1987 |